Skip to content

Proto Labs PRLB Injection Molding — Revenue

Similar metrics at other companies

Amneal Pharmaceuticals, Inc. logo
AMRXInjectable — Net revenue
$49.94M+43.5%
ICU Medical logo
ICUIInfusion Systems — Revenue
$179.6M+8.0%
Trinity Industries logo
TRNManufacturing — Revenue
$206.7M-30.7%
ICU Medical logo
ICUIInfusion Consumables — Revenue
$278.28M+4.5%
HWK
HWKNManufactured, blended or repackaged products — Revenue
$149.72M+14.9%
OTT
OTTRPlastic Products and Tooling — Total Operating Revenues
$9.84M+9.8%

Other financials

Income statement

See full
Revenue$139.3M+10.4%
Gross profit$63.6M+14.2%
Operating income$9.8M+117%
Net income$8.1M+125%
EPS (diluted)$0.33+120%

Balance sheet

See full
Cash & equivalents$124.0M+49.9%
Total debt$2.6M-16.6%
Total equity$683.1M+4.0%
Total assets$778.6M+5.6%

Cash flow

See full
Operating cash flow$17.5M-4.6%
CapEx$3.5M+181%
Free cash flow$14.0M-18.2%

Valuation

See full
Market cap$1.9B+59.7%

Profitability

See full
Gross margin44.9%+0.5pp
Operating margin5.6%+1.7pp
Net margin4.7%+1.6pp
FCF margin10.4%-3.1pp

Returns & leverage

See full
Return on equity3.8%+1.6pp
Debt / equity0.0×
Current ratio3.5×+0.4×

Where this comes from

Reported directly by Proto Labs in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Proto Labs’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Proto Labs's injection molding — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Proto Labs's injection molding — revenue?
Proto Labs (PRLB) reported injection molding — revenue of $51.07M in Q1 2026.
What does injection molding — revenue mean?
This metric represents the total net sales generated from injection molding manufacturing services provided to customers. It reflects the demand for the company's rapid prototyping and short-run production capabilities within this specific manufacturing process. Tracking this revenue stream helps investors assess the market adoption and competitive positioning of the company's core on-demand molding services.